Alefacept - Amevive; leukocyte function-associated antigen-3/immune globulin G (IgG) fusion protein, recombinant -- Product Record

LFA-3/IgG1, rDNA

    Nomenclature:
      LFA-3/IgG1, rDNA [SY]
      Alefacept [FDA]
      Amevive [TR]
      1-92-LFA-3 (antigen) (human) fusion protein with immunoglobulin G1 (human hinge-CH2-Ch3 gamma1-chain), dimer [CAS]
      222535-22-0 [CAS RN]
      BG-9273 [SY]
      BG-9712 [SY]
      leukocyte function-associated antigen-3/IgG1 fusion protein, recombinant [SY]
      LFA-3 fusion protein [SY]
      LFA-3(92)IgG [SY]
      LFA-3/IgG1 fusion protein [SY]
      LFA3TIP [SY]
      NDC 59627-020-01; NDC 59627-020-02; NDC 59627-021-03; and NDC 59627-021-04 [NDC]

    molecular weight (kDa) = 91

    FDA Class:  Biologic

    Year of approval (FDA) = 2003